https://pubmed.ncbi.nlm.nih.gov/36559247/
OX40-OX40L Inhibition for the Treatment of Atopic Dermatitis-Focus on Rocatinlimab and Amlitelimab
Despite the recent emergence of targeted therapeutic options, there are still unmet needs concerning moderate-to-severe atopic dermatitis treatment. This...
https://allergylosangeles.com/allergy-blog/ox40-inhibitors-atopic-dermatitis/
OX40/OX40L Inhibitors: Are Amlitelimab and Rocatinlimab the Next Generation of Atopic Dermatitis...
Jul 9, 2026 - Learn how OX40 and OX40L inhibitors like amlitelimab and rocatinlimab may transform atopic dermatitis treatment, including clinical trials, safety, and future...
the next generation